Metformin Is Associated with a Lower Risk of Atrial Fibrillation and Ventricular Arrhythmias Compared to Sulfonylureas: An Observational Study

Effect of Dapagliflozin on Atrial Fibrillation in Patients with Type 2 Diabetes Mellitus: Insights from the DECLARE-TIMI 58 Trial

(2020) Thomas A. Zelniker et al.   CIRCULATION

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM – 2020 EXECUTIVE SUMMARY

(2020) Alan J. Garber et al.   Endocrine Practice

A Safety Comparison of Metformin vs Sulfonylurea Initiation in Patients With Type 2 Diabetes and Chronic Kidney Disease: A Retrospective Cohort Study

(2020) Reid H. Whitlock et al.   MAYO CLINIC PROCEEDINGS

Lipid Accumulation in Hearts Transplanted From Nondiabetic Donors to Diabetic Recipients

(2020) Raffaele Marfella et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Metformin regulates lipid metabolism in a canine model of atrial fibrillation through AMPK/PPAR-α/VLCAD pathway

(2019) Fan Bai et al.   Lipids in Health and Disease

Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis

(2019) Marc A Suchard et al.   LANCET

Antihyperglycemic drugs use and new-onset atrial fibrillation: A population-based nested case control study

(2018) Yi-Sheng Liou et al.   PLoS One

Metformin regulates atrial SK2 and SK3 expression through inhibiting the PKC/ERK signaling pathway in type 2 diabetic rats

(2018) Chang-He Liu et al.   BMC Cardiovascular Disorders

Characterizing treatment pathways at scale using the OHDSI network

(2016) George Hripcsak et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Adiponectin, the past two decades

(2016) Zhao V. Wang et al.   Journal of Molecular Cell Biology

Comparison of Epicardial Adipose Tissue Volume and Coronary Artery Disease Severity in Asymptomatic Adults With Versus Without Diabetes Mellitus

(2014) Elliott M. Groves et al.   AMERICAN JOURNAL OF CARDIOLOGY

Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies

(2014) Shang-Hung Chang et al.   Cardiovascular Diabetology

7. Approaches to Glycemic Treatment

(2014)   DIABETES CARE

Interpreting observational studies: why empirical calibration is needed to correctp-values

(2013) Martijn J. Schuemie et al.   STATISTICS IN MEDICINE

Secretory Products From Epicardial Adipose Tissue of Patients With Type 2 Diabetes Mellitus Induce Cardiomyocyte Dysfunction

(2012) Sabrina Greulich et al.   CIRCULATION

Causes of nonischemic sudden cardiac death in the current era

(2011) Eeva Hookana et al.   HEART RHYTHM

Cardiac fibrosis and vascular remodeling are attenuated by metformin in obese rats

(2011) Adriana K. Burlá et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

In vitro and in vivo Effects of Metformin on Human Adipose Tissue Adiponectin

(2011) Alessandra Zulian et al.   Obesity Facts

Metformin Use and Mortality Among Patients With Diabetes and AtherothrombosisMetformin Use With Diabetes and Atherothrombosis

(2010) Ronan Roussel   ARCHIVES OF INTERNAL MEDICINE

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE